Please sign in to follow a disease.
Bile duct neoplasm
MONDO:0021662A benign or malignant neoplasm that affects the intrahepatic or extrahepatic bile ducts. Representative examples of benign neoplasms include bile duct adenoma and extrahepatic bile duct lipoma. Representative examples of malignant neoplasms include intrahepatic and extrahepatic cholangiocarcinoma.
Also known as: bile duct neoplasm, bile duct neoplasm (disease), bile duct tumor, bile duct tumour, intrahepatic and extrahepatic bile duct neoplasm, intrahepatic and extrahepatic bile duct tumor, intrahepatic and extrahepatic bile duct tumour, neoplasm of bile duct
1920 clinical trials for this condition and its sub-types, 41 tagged with Bile duct neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bile duct neoplasm
-
Bile duct cancer 34 trials · 471 incl. sub-types
4 sub-types
- Bile duct carcinoma 20 trials · 454 incl. sub-types Sub-types →
- Malignant tumor of extrahepatic bile duct 1 trial · 434 incl. sub-types Sub-types →
- Intrahepatic bile duct cancer 6 trials · 179 incl. sub-types Sub-types →
- Bile duct sarcoma 0 trials Sub-types →
-
Extrahepatic bile duct neoplasm 0 trials · 434 incl. sub-types
7 sub-types
- Malignant tumor of extrahepatic bile duct 1 trial · 434 incl. sub-types Sub-types →
- Carcinoma of gallbladder and extrahepatic biliary tract 1 trial · 374 incl. sub-types Sub-types →
- Common bile duct neoplasm 2 trials · 71 incl. sub-types Sub-types →
- Extrahepatic bile duct adenoma 0 trials Sub-types →
- Extrahepatic bile duct leiomyoma 0 trials
- Extrahepatic bile duct lipoma 0 trials
- Gallbladder neuroendocrine tumor, grade 1/2 0 trials
-
Bile duct adenoma 0 trials
3 sub-types
- Bile duct cystadenoma 0 trials Sub-types →
- Extrahepatic bile duct adenoma 0 trials Sub-types →
- Intrahepatic bile duct adenoma 0 trials Sub-types →
-
Bile duct papillary neoplasm 0 trials
3 sub-types
- Extrahepatic bile duct papillary adenoma 0 trials
- Extrahepatic biliary papillomatosis 0 trials
- Intrahepatic biliary papillomatosis 0 trials
Most studied deeper sub-types
-
New combo immunotherapy drug enters human trials for 18 cancers
Disease control CompletedThis early-phase trial tests a new drug called AI-061, which combines two immune-boosting antibodies (anti-PD-1 and anti-CTLA-4) into one treatment. The study will enroll 18 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to find a safe…
Phase 1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Immunotherapy drug shows promise in bile duct cancer trial
Disease control CompletedThis Phase 3 trial tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine and cisplatin) helps people with advanced bile duct cancer live longer. The study enrolled 158 Chinese adults with cancer that had spread or could not be removed by…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immunotherapy combo shows promise for tough bile duct cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine/cisplatin) helps people with advanced bile duct or gallbladder cancer live longer. Over 1,000 participants received either the combination or chemo plus a placebo. The goal…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Robotic vs open: which whipple surgery is safer for pancreatic cancer?
Disease control CompletedThis study compared miniinvasive (robotic or laparoscopic) Whipple surgery to the traditional open approach in 320 patients with pancreatic, bile duct, or ampulla of Vater cancers. The goal was to see which method leads to fewer complications like pancreatic leaks, bleeding, or i…
Sponsor: State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo shows promise for Tough-to-Treat bile duct cancer
Disease control CompletedThis phase 2 trial tested a new chemotherapy combination (Nal-IRI with 5-FU and leucovorin) against a standard treatment (gemcitabine plus cisplatin) in 93 people with advanced biliary tract cancer that could not be removed by surgery. The study aimed to see which approach better…
Phase 2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Experimental Vaccine-Like therapy targets Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested an experimental immunotherapy called ELI-002 in 25 people with KRAS-mutated pancreatic, colorectal, lung, ovarian, or bile duct cancers who had signs of remaining disease after standard treatment. The therapy aims to train the immune system to attack…
Phase 1 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 13:30 UTC
-
PET-CT scans could sharpen radiation targeting for liver tumors
Knowledge-focused CompletedThis study investigates whether PET-CT scans can accurately measure the radiation dose delivered by radioactive spheres during a liver cancer treatment called radioembolization. Researchers will compare scans taken before and after the procedure in patients with liver tumors. The…
Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC